Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;41(5):208-12.
doi: 10.4103/0253-7613.58508.

Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat

Affiliations

Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat

Banappa S Unger et al. Indian J Pharmacol. 2009 Oct.

Abstract

Background and objectives: Exaggerated production of superoxide and inactivation of nitric oxide have been implicated in pathogenesis of hypertension. NAD(P)H oxidase is one of the major source of reactive oxygen species in vasculature. In the present study, we aimed to determine the effect of chronic administration of Apocynin an NAD(P)H oxidase inhibitor on endothelial function and hypertension in fructose-fed rat.

Materials and methods: Endothelial function, vascular superoxide, and nitric oxide production/bioavailability in aortas from fructose-fed rats and age-matched controls treated with or without apocynin were assessed using isometric tension studies in organ chambers. Systolic blood pressure was measured by the tail cuff method.

Results: In fructose-fed rats, acetylcholine-induced relaxation was impaired, vascular superoxide production was increased, and nitric oxide bioavailability was decreased along with an increase in systolic blood pressure compared to controls. Apocynin treatment prevented the increased generation of superoxide, decreased nitric oxide bioavailability, impaired acetylcholine-induced relaxation, and elevation of systolic blood pressure.

Conclusion: Chronic administration of apocynin improves the endothelial function by reducing oxidative stress, improving NO bioavailability, and prevents the development hypertension in fructose-fed rat.

Keywords: NAD(P)H oxidase; Superoxide; apocynin; endothelial dysfunction; hypertension; nitric oxide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Systolic blood pressure in control and fructose fed-animals treated with or without apocynin. Control, control + apocynin, fructose fed, fructose + apocynin. **P < 0.01 F vs. C, **P < 0.01 FA vs. F
Figure 2
Figure 2
Acetylcholine-induced relaxation of isolated rat aorta preconstricted with phenylephrine in control and fructose-fed animals treated with or without apocynin. Control, control + apocynin, fructose fed, fructose + apocynin. *P < 0.05 F vs. C, *P < 0.05 FA vs. F
Figure 3
Figure 3
Sodium nitroprusside-induced relaxation of isolated rat aorta preconstricted with phenylephrine in control and fructose-fed animals treated with or without apocynin. Control, control + apocynin, fructose fed, fructose + apocynin
Figure 4
Figure 4
Super-oxide level measured as tempo-induced relaxation of isolated rat aorta preconstricted with phenylephrine in control and fructose-fed animals treated with or without apocynin. Control, control + apocynin, fructose fed, fructose + apocynin. **P < 0.01 F vs. C, **P < 0.01 FA vs. F
Figure 5
Figure 5
Nitric oxide level measured as L-NAME-induced contraction of isolated rat aorta preconstricted with phenylephrine in control and fructose-fed animals treated with or without apocynin. Control, control + apocynin, fructose fed, fructose + apocynin. *P < 0.05 F vs. C, *P < 0.05 FA vs. F

Similar articles

Cited by

References

    1. Touyz RM, Paravicini TM. Redox signaling in hypertension. Cardiovasc Res. 2006;71:247–58. - PubMed
    1. Ceriello A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care. 2008;31:S181–4. - PubMed
    1. Vaziri ND, Rodríguez-Iturbe B. Mechanisms of disease: Oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol. 2006;2:582–93. - PubMed
    1. Lassègue B, Griendling KK. Reactive oxygen species in hypertension. Am J Hypertens. 2004;17:852–60. - PubMed
    1. Cifuentes ME, Pagano PJ. Targeting reactive oxygen species in hypertension. Curr Opin Nephrol Hypertens. 2006;15:179–86. - PubMed